
Deprescribing in Psychiatry
Oxford University Press Inc
Published on 16. October 2019
Book
Paperback/Softback
264 pages
978-0-19-065481-8 (ISBN)
Description
The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits.
Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.
As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.
Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.
As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.
More details
Language
English
Place of publication
New York
United States
Target group
College/higher education
Dimensions
Height: 234 mm
Width: 156 mm
Thickness: 14 mm
Weight
404 gr
ISBN-13
978-0-19-065481-8 (9780190654818)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Swapnil MD Gupta | John MBBS Cahill | Rebecca Miller
Deprescribing in Psychiatry
E-Book
08/2019
OUP eBook
€39.49
Available for download

Swapnil MD Gupta | John MBBS Cahill | Rebecca Miller
Deprescribing in Psychiatry
E-Book
08/2019
OUP eBook
€39.49
Available for download
Persons
Swapnil Gupta, MBBS, MD Assistant Professor, Department of Psychiatry, Yale University School of Medicine;John D. Cahill, BMBS, PhD, , Assistant Professor, Department of Psychiatry, Yale University School of Medicine; Rebecca Miller, PhD, Assistant Professor, Department of Psychiatry, Yale University School of Medicine
Author
Assistant ProfessorAssistant Professor, Yale University School of Medicine
Assistant ProfessorAssistant Professor, Yale University School of Medicine
Assistant ProfessorAssistant Professor, Yale University School of Medicine
Content
Preface
Chapter 1 Introduction
Chapter 2 Decision making in deprescribing
Chapter 3 Barriers to deprescribing
Chapter 4 Non pharmacological considerations
Chapter 5 Wellness approaches I: Self-determined strategies
Chapter 6 Wellness approaches II: Collaborative strategies
Chapter 7 Process of deprescribing Chapter 8 Deprescribing antidepressant medications Chapter 9 Deprescribing antipsychotic medications
Chapter 10 Deprescribing mood stabilizers medications
Chapter 11 Deprescribing benzodiazepine and stimulants
Chapter 12 Conclusions and future directions
Afterword
Chapter 1 Introduction
Chapter 2 Decision making in deprescribing
Chapter 3 Barriers to deprescribing
Chapter 4 Non pharmacological considerations
Chapter 5 Wellness approaches I: Self-determined strategies
Chapter 6 Wellness approaches II: Collaborative strategies
Chapter 7 Process of deprescribing Chapter 8 Deprescribing antidepressant medications Chapter 9 Deprescribing antipsychotic medications
Chapter 10 Deprescribing mood stabilizers medications
Chapter 11 Deprescribing benzodiazepine and stimulants
Chapter 12 Conclusions and future directions
Afterword